Literature DB >> 15117317

Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation.

Sophia Kiachopoulos1, Johanna Heske, Jörg Tatzelt, Konstanze F Winklhofer.   

Abstract

Suramin induces misfolding of the cellular prion protein (PrP(C)) and interferes with the propagation of infectious scrapie prions. A mechanistic analysis of this effect revealed that suramin-induced misfolding occurs at the plasma membrane and is dependent on the proximal region of the C-terminal domain (aa 90-158) of PrP(C). The conformational transition induces rapid internalization, mediated by the unstructured N-terminal domain, and subsequent intracellular degradation of PrP(C). As a consequence, PrP Delta N adopts a misfolded conformation at the plasma membrane; however, internalization is significantly delayed. We also found that misfolding and intracellular retention of PrP(C) can be induced by copper and that, moreover, copper interferes with the propagation of the pathogenic prion protein (PrP(Sc)) in scrapie-infected N2a cells. Our study revealed a quality control pathway for aberrant PrP conformers present at the plasma membrane and identified distinct PrP domains involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117317     DOI: 10.1111/j.1398-9219.2004.00185.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  17 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Sequence-dependent internalization of aggregating peptides.

Authors:  José R Couceiro; Rodrigo Gallardo; Frederik De Smet; Greet De Baets; Pieter Baatsen; Wim Annaert; Kenny Roose; Xavier Saelens; Joost Schymkowitz; Frederic Rousseau
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

3.  Conditional modulation of membrane protein expression in cultured cells mediated by prion protein recognition of short phosphorothioate oligodeoxynucleotides.

Authors:  Marcela Viviana Karpuj; Sagit Gelibter-Niv; Anat Tiran; Angelika Rambold; Jörg Tatzelt; Max Nunziante; Hermann M Schatzl
Journal:  J Biol Chem       Date:  2010-12-14       Impact factor: 5.157

4.  Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.

Authors:  Uwe Bertsch; Konstanze F Winklhofer; Thomas Hirschberger; Jan Bieschke; Petra Weber; F Ulrich Hartl; Paul Tavan; Jörg Tatzelt; Hans A Kretzschmar; Armin Giese
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Observing fibrillar assemblies on scrapie-infected cells.

Authors:  Susanne Wegmann; Margit Miesbauer; Konstanze F Winklhofer; Jörg Tatzelt; Daniel J Muller
Journal:  Pflugers Arch       Date:  2008-01-03       Impact factor: 3.657

Review 6.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

7.  Novel Compounds Identified by Structure-Based Prion Disease Drug Discovery Using In Silico Screening Delay the Progression of an Illness in Prion-Infected Mice.

Authors:  Daisuke Ishibashi; Takeshi Ishikawa; Satoshi Mizuta; Hiroya Tange; Takehiro Nakagaki; Tsuyoshi Hamada; Noriyuki Nishida
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Opposing roles of prion protein in oxidative stress- and ER stress-induced apoptotic signaling.

Authors:  Vellareddy Anantharam; Arthi Kanthasamy; Christopher J Choi; Dustin P Martin; Calivarathan Latchoumycandane; Jüergen A Richt; Anumantha G Kanthasamy
Journal:  Free Radic Biol Med       Date:  2008-09-13       Impact factor: 7.376

9.  Selective processing and metabolism of disease-causing mutant prion proteins.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  PLoS Pathog       Date:  2009-06-19       Impact factor: 6.823

Review 10.  Prion protein and metal interaction: physiological and pathological implications.

Authors:  Neena Singh; Dola Das; Ajay Singh; Maradumane L Mohan
Journal:  Curr Issues Mol Biol       Date:  2009-09-18       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.